ST Segment Elevation Myocardial Infarction
Over 1.2 million patients suffer from new or recurrent ischemic events annually. This includes an estimated 565,000 cases of first and 300,000 cases of recurrent myocardial infarction. Although mortality from acute myocardial infarction (AMI) has declined in recent years, it still remains high at 25–30%. The most common cause of ST elevation AMI (STEMI) is acute plaque rupture with the resultant thrombosis leading to acute closure of coronary arteries.
KeywordsPercutaneous Coronary Intervention Acute Myocardial Infarction Primary Percutaneous Coronary Intervention Pulmonary Congestion Fibrinolytic Therapy
- 2.Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Lancet. 1994;343:311–322.Google Scholar
- 4.Thompson CR, Buller CE, Sleeper LA, et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000;36:1104–1109.Google Scholar